Naringenin Protected Against Blood Brain Barrier Breakdown after Ischemic Stroke through GSK-3β/ β-Catenin Pathway
- 18 November 2024
- journal article
- research article
- Published by Springer Nature in Neurochemical Research
- Vol. 50 (1) , 1-14
Abstract
Protection against blood-brain barrier (BBB) dysfunction is key to reduce the cerebral ischemia injury as its breakdown causes edema formation and extravasation of blood components and immune cells. The maintenance of BBB integrity requires the GSK-3β/β-catenin pathway activity. Naringenin (NAR), an effective monomer from Chinese herbal medicine, had potent protective effect on brain inflammatory and oxidative injury. However, whether NAR could protect the integrity of BBB during cerebral ischemia injury and the involvement of GSK-3β/β-catenin pathway in the beneficial effect of NAR was unknown. Therefore, mouse middle cerebral artery occlusion/reperfusion (IR) model was employed to answer these questions. NAR was intraperitoneally administrated once daily for 6 days immediately after IR with the dose of 10 mg/kg. BBB damage was evaluated with Evans blue. Protein levels of GSK-3β and β-catenin in vascular endothelial cells at penumbra were assessed with western blotting and immunofluorescence. The experimental data suggested that NAR improved neurological deficits, decreased the percentage of infarct volumes and neuronal apoptosis at 7d after IR. NAR improved BBB damage as evidenced by a lower permeability of Evans blue dye and upregulation of tight junction proteins such as zonula occludens-1(ZO-1), Occludin and Claudin-5. Importantly, GSK-3β/β-catenin pathway activity was related to the improvement of BBB integrity rendered by NAR. Our findings demonstrated that NAR might become a potential therapeutic drug for IR.Keywords
Funding Information
- The National Natural Science Foundation of China (82171322)
- the Shaanxi Provincial Natural Science Foundation (2023-JC-YB-652)
This publication has 37 references indexed in Scilit:
- γ-Glutamylcysteine ameliorates blood-brain barrier permeability and neutrophil extracellular traps formation after ischemic stroke by modulating Wnt/β-catenin signalling in miceEuropean Journal of Pharmacology, 2024
- Acteoside alleviates blood–brain barrier damage induced by ischemic stroke through inhibiting microglia HMGB1/TLR4/NLRP3 signalingBiochemical Pharmacology, 2023
- Traditional Chinese medicines treat ischemic stroke and their main bioactive constituents and mechanismsPhytotherapy Research, 2023
- Adiponectin Promotes Neurogenesis After Transient Cerebral Ischemia Through STAT3 Mediated BDNF Upregulation in AstrocytesNeurochemical Research, 2022
- Naringenin: A potential flavonoid phytochemical for cancer therapyLife Sciences, 2022
- Factors influencing the blood-brain barrier permeabilityBrain Research, 2022
- Functional morphology of the blood–brain barrier in health and diseaseActa Neuropathologica, 2018
- Glycogen Synthase Kinase-3β Is Involved in Electroacupuncture Pretreatment via the Cannabinoid CB1 Receptor in Ischemic StrokeMolecular Neurobiology, 2013
- Wnt/β-Catenin Signaling and DiseaseCell, 2012
- Effects of the chemically synthesized flavanone 7-(O-prenyl)naringenin-4′-acetate on the estrogen signaling pathway in vivo and in vitroThe Journal of Steroid Biochemistry and Molecular Biology, 2007